Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood Biomarkers.

JAMA network open(2023)

引用 0|浏览9
暂无评分
摘要
In this diagnostic study of patients with pancreatic cancer or benign periampullary diseases, an easily applicable risk score showed high accuracy for distinguishing early-stage pancreatic cancer from benign periampullary diseases. This model could be used to assess the added diagnostic and clinical value of novel biomarkers and prevent potentially unnecessary invasive diagnostic procedures for patients at low risk.
更多
查看译文
关键词
pancreatic cancer,prediction model,early-stage
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要